Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

NR4A1 agonist 1

Catalog No. T213234 Copy Product Info
🥰Excellent
NR4A1 agonist 1 is an NR4A1 agonist with a Ki value of 2.96 μM. It demonstrates significant lipid-lowering activity in 3T3-L1 adipocytes, with an EC50 of 0.13 μM, effectively reducing triglyceride (TG) accumulation and lipid droplet formation. NR4A1 agonist 1 is applicable in obesity-related research.

NR4A1 agonist 1

Copy Product Info
🥰Excellent
Catalog No. T213234

NR4A1 agonist 1 is an NR4A1 agonist with a Ki value of 2.96 μM. It demonstrates significant lipid-lowering activity in 3T3-L1 adipocytes, with an EC50 of 0.13 μM, effectively reducing triglyceride (TG) accumulation and lipid droplet formation. NR4A1 agonist 1 is applicable in obesity-related research.

NR4A1 agonist 1
Cas No. 1825366-87-7
Pack SizePriceUSA StockGlobal StockQuantity
10 mgInquiry10-14 weeks10-14 weeks
50 mgInquiry10-14 weeks10-14 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Resource Download

Product Introduction

Bioactivity
Description
NR4A1 agonist 1 is an NR4A1 agonist with a Ki value of 2.96 μM. It demonstrates significant lipid-lowering activity in 3T3-L1 adipocytes, with an EC50 of 0.13 μM, effectively reducing triglyceride (TG) accumulation and lipid droplet formation. NR4A1 agonist 1 is applicable in obesity-related research.
In vitro
NR4A1 agonist 1 (Compound R17), at concentrations of 1-5 μM, reduces the F1 fluorescence intensity in si-NR4A1 transfected 3T3-L1 cells in a dose-dependent manner. It also exhibits a significantly weakened triglyceride-lowering effect at 0.125-0.25 μM in these cells compared to the si-NC group. Additionally, NR4A1 agonist 1 (0.125-0.25 μM) reduces lipid droplet accumulation in si-NC transfected 3T3-L1 cells. After 48 hours of treatment at 0.125-0.25 μM, it downregulates mRNA expression levels of lipid synthesis-related genes FABP4, CD36, SLC25A10, SLC5A6, and ALDH2 in 3T3-L1 cells.
Chemical Properties
Molecular Weight373.46
FormulaC22H23N5O
Cas No.1825366-87-7
SmilesO=CC=1C=2C=CC=CC2NC1C=3N=C4C=CC=CC4=C(N3)NCCCN(C)C
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.

Citations

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy NR4A1 agonist 1 | purchase NR4A1 agonist 1 | NR4A1 agonist 1 cost | order NR4A1 agonist 1 | NR4A1 agonist 1 in vitro | NR4A1 agonist 1 formula | NR4A1 agonist 1 molecular weight